Jeffrey M. Sesplankis - 01 Mar 2026 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: SVP, Chief Accounting Officer
Signature: /s/ Elizabeth C. Radigan, Attorney-in-fact for Jeffrey M. Sesplankis
Issuer symbol: DBD
Transactions as of: 01 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2026, 18:20:51 UTC
Previous filing: 09 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sesplankis Jeffrey M	SVP, Chief Accounting Officer	C/O DIEBOLD NIXDORF, INCORPORATED, 350 ORCHARD AVENUE NE, NORTH CANTON	/s/ Elizabeth C. Radigan, Attorney-in-fact for Jeffrey M. Sesplankis	09 Mar 2026	0001719391

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBD	Common Stock	Tax liability		-672	-12%	$80.00^*	5,129	01 Mar 2026	Direct	F1, F2
transaction	DBD	Common Stock	Award		+2,215	+43%	$0.000000^*	7,344	01 Mar 2026	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld pursuant to exercise of tax withholding right under the 2023 Equity and Incentive Plan, as amended.
F2	Number includes Restricted Stock Units.
F3	Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.